These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 24950946

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods.
    Kwak MS, Kim E, Jang EJ, Kim HJ, Lee CH.
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2365-76. PubMed ID: 26604734
    [Abstract] [Full Text] [Related]

  • 5. Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis.
    Rodrigo GJ, Castro-Rodriguez JA, Nannini LJ, Plaza Moral V, Schiavi EA.
    Respir Med; 2009 Oct; 103(10):1421-9. PubMed ID: 19556116
    [Abstract] [Full Text] [Related]

  • 6. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.
    Salpeter SR.
    Drugs; 2009 Oct 22; 69(15):2025-33. PubMed ID: 19791824
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cardiovascular safety of tiotropium in patients with COPD.
    Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin DP.
    Chest; 2010 Jan 22; 137(1):20-30. PubMed ID: 19592475
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF.
    Expert Opin Investig Drugs; 2010 Feb 22; 19(2):257-64. PubMed ID: 20047505
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
    Halpin DM, Kaplan AG, Russell RK.
    Respir Med; 2017 Jul 22; 128():28-41. PubMed ID: 28610667
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A, Croxford R, Calzavara A, To T, Stanbrook MB, Upshur R, Stukel TA.
    JAMA Intern Med; 2013 Jul 08; 173(13):1175-85. PubMed ID: 23689820
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study.
    Sauer R, Hänsel M, Buhl R, Rubin RA, Frey M, Glaab T.
    Int J Chron Obstruct Pulmon Dis; 2016 Jul 08; 11():891-8. PubMed ID: 27217742
    [Abstract] [Full Text] [Related]

  • 20. Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach.
    Lin HW, Chung CL, Lin YS, Yu CM, Lee CN, Bien MY.
    PLoS One; 2015 Jul 08; 10(7):e0130102. PubMed ID: 26158649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.